Chennai, Nov. 26 -- Highlights: ...

The first gene-editing therapies for HIV/Aids are entering trials but the virus is proving once again that it is a master at ...

In addition to being the third consecutive supermoon of the year, as reported by EarthSky, it will be about 357,000 km away ...

CRISPR technology, a revolutionary tool in genetic engineering, has empowered Lambert's iGEM team to tackle a significant health issue: Lyme disease, which affects nearly half a million Americans ...

CRISPR Therapeutics AG (NASDAQ:CRSP) ranks among the best short squeeze stocks to buy right now. Citizens reaffirmed its ...

Although existing CRISPR-Cas-based imaging methods can target endogenous genomic sequences, their applications are limited by system complexity and sensitivity, particularly when imaging ...

Thinking about whether CRISPR Therapeutics stock is truly a bargain or just the next biotech craze? Let’s break down its value case together. After a sharp rally earlier this year, the stock is still ...

The gene editing tool known as CRISPR-Cas9 is changing what's possible for treating a wide range of diseases caused by genetic mutations. But so far, attempts to use the technology to address ...

The immune system plays a crucial role in fighting tumors and metastases. Consequently, it is decisive to conduct cancer ...

After revoking Sarepta’s award in July and awarding one to Krystal last month, the FDA’s platform technology designation program appears to be back on track. These six biotechs could be on the ...

For years, Yale researchers David Breslow and Mustafa Khokha have worked together with a similar challenge in their ...